{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:11:25Z","timestamp":1771233085795,"version":"3.50.1"},"reference-count":23,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Lifetech Multifunctional occluder is a versatile device with an improved delivery and flexibility that reduces the risk of atrioventricular block. This is a retrospective, descriptive, pilot study done in 25 patients who underwent transcatheter closure of ventricular septal defect using Lifetech Multifunctional occluder from February 2017 to January 2018.<\/jats:p><jats:p>The average age was 9.32\u00a0\u00b1\u00a07.20 years, with a range from 1 to 32 years. Procedural success was 100% with no case needing a change of device size. Closure rate on follow up was at 42% (10\/24), 52% (12\/23), and 81% (17\/21) at 1 day, 1 month, and 6 months, respectively. At 6-month follow up, pre-procedure tricuspid regurgitation disappeared by 38%. However, the incidence of new onset tricuspid regurgitation to trace was 16% (2) and mild 8% (1). Pre-procedure mild aortic regurgitation remained the same status throughout the 6-month follow up. Closure of the defect did not improve or worsen the aortic regurgitation. Post-transcatheter closure of ventricular septal defect with mild infundibular hypertrophy, the 1-year-old patient had resolution of the infundibular hypertrophy after 6 months but our 9-year-old patient had persistence of the mild infundibular hypertrophy even after 6 months. One patient (4%) developed transient widened QRS complexes post-transcatheter closure that resolved after 1 month. In total, 92% of the patients had no periprocedural complications. While one patient each had an inadvertent urinary bladder puncture and device embolisation.<\/jats:p><jats:p>Our retrospective review of the procedural and short-term outcomes of transcatheter closure of ventricular septal defect sizes 2\u201310\u00a0mm, using the Lifetech Multifunctional occluder, appears to be safe and effective. However, long-term follow up is warranted.<\/jats:p>","DOI":"10.1017\/s1047951120004229","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T04:07:17Z","timestamp":1607573237000},"page":"435-445","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Procedural and short-term outcomes of transcatheter closure of ventricular septal defect using lifetech multifunctional occluder: initial experience"],"prefix":"10.1017","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-8005","authenticated-orcid":false,"given":"Judah D.","family":"Gozar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexter E. D.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose J. D.","family":"Del Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"S1047951120004229_ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezt003"},{"key":"S1047951120004229_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01886-7"},{"key":"S1047951120004229_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.008"},{"key":"S1047951120004229_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23084"},{"key":"S1047951120004229_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23344"},{"key":"S1047951120004229_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90460-8"},{"key":"S1047951120004229_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.04.030"},{"key":"S1047951120004229_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm314"},{"key":"S1047951120004229_ref23","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12739"},{"key":"S1047951120004229_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.014"},{"key":"S1047951120004229_ref21","unstructured":"21. Lifetech Product Cera VSD occluder. http:\/\/www.lifetechmed.com\/en\/product\/p1\/cera\/282.aspx"},{"key":"S1047951120004229_ref14","first-page":"322","article-title":"Transcatheter closure of con- genital and acquired muscular ventricular septal defects using the Amplatzer device","volume":"14","author":"Chessa","year":"2002","journal-title":"J Invasive Cardiol"},{"key":"S1047951120004229_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61339-6"},{"key":"S1047951120004229_ref12","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.084988"},{"key":"S1047951120004229_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.01.015"},{"key":"S1047951120004229_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90120-1"},{"key":"S1047951120004229_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.04.012"},{"key":"S1047951120004229_ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm314"},{"key":"S1047951120004229_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.03.068"},{"key":"S1047951120004229_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2011.06.008"},{"key":"S1047951120004229_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.10.047"},{"key":"S1047951120004229_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(67)90476-6"},{"key":"S1047951120004229_ref18","unstructured":"18. Koneti, NR . LifeTech Scientific Corporation Attends CSI Asia Pacific 2017. 2017 March 2. http:\/\/www.lifetechmed.com\/en\/news\/n1\/20170316\/1797.aspx"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951120004229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T09:55:38Z","timestamp":1662717338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951120004229\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1047951120004229"],"URL":"https:\/\/doi.org\/10.1017\/s1047951120004229","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"\u00a9 The Author(s), 2020. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}